AANMA is offering guidance to help patients understand recent Food and Drug Administration (FDA) warnings about Advair ® (fluticasone and salmeterol), Foradil ® (formoterol), Serevent ® (salmeterol) and Symbicort ® (budesonide and formoterol), daily inhaled medications containing a long-acting beta agonist (LABA, a 12-hour bronchodilator). The FDA had two basic messages on Feb. 18: Read the rest of this entry »

AANMA’s Director of Patient Advocacy, Sandra Fusco-Walker, testifed before the South Dakota Health and Human Services via phone this morning on Senate Bill 83, which would protect a student’s right to carry and self-administer their lifesaving asthma and anaphylaxis medications at school. Once the legislation passes, South Dakota would become Read the rest of this entry »

The AANMA Store is now open for business! Our new online store brings you the best resources and products to help you manage symptoms, plus a vibrant selection of books and educational materials. Shop for holding chambers and nebulizers, peak flow meters, books, the AsthmaTracker(TM) daily symptom diary and our popular series of inhaler posters. Read the rest of this entry »